Physician's Weekly4d
Epicardial Fat and Heart Failure with Preserved Ejection Fraction
The following is a summary of "Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure ...
Medscape4d
Pharmacologic Management of Heart Failure with Preserved Ejection Fraction
[21] This was a smaller study that enrolled 74 patients 65 years and older with NYHA class II or III heart failure (defined by the Framingham criteria) and an ejection fraction ≥40%. Background ...
AHA/ASA Journals4d
Lymphatic Endothelial Branched-Chain Amino Acid Catabolic Defects Undermine Cardiac Lymphatic Integrity and Drive HFpEF
BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) has become the most prevalent type of heart failure, but ...
Monthly Prescribing Reference8d
Heart Failure Patients With Ejection Fraction Improvement Rarely Withdrawn From Meds
HealthDay News — In patients with heart failure with improved ejection fraction (EF), pharmacological therapy is rarely withdrawn, according to a study published online March 17 in Circulation.
Using AI to calculate the heart's biological age predicts increased risk of mortality, cardiovascular events: Study
While everybody's heart has an absolute chronological age (as old as that person is), hearts also have a theoretical ...
EurekAlert!6d
Mode of death in patients with heart failure with mildly reduced or preserved ejection fraction
Among patients with heart failure with mildly reduced ejection fraction/heart failure with preserved ejection fraction in the Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in ...